Table of contents

ABN Abstracts 2016

• 001: RETROSPECTIVE STUDY OF STATUS EPILEPTICUS IN ADULTS IN GLASGOW FROM 1996–2013 (15 November, 2016)

  Hina Abbasi, John Paul Leach
• 002: OPTIMISING THE IVIG SERVICE: AN AUDIT OF MONITORING AND DOSAGE (15 November, 2016)

  Scherezade Sarr-Gonzales, Angeliki Zarkali, Guendalina Bonifacio, Christina Englezou, Hadi Manji, Matt Parton, Mike Hanna, Mike Lunn, Mary Reilly, Aisling Carr
• 003: THE ESSENTIAL NEUROLOGICAL EXAMINATION: AN EVIDENCE-BASED, YOUTUBE APPROACH? (15 November, 2016)

  Ghaniah Hassan-Smith, David Nicholl
• 004: PATIENTS SHOULD BE ACTIVE PARTICIPANTS IN GRAND ROUNDS BUT ARE STUDENTS READY? (15 November, 2016)

  Frederick Schon, Hannah Cock, Jayna Mistry
• 005: A RISK-STRATIFYING TOOL TO ENABLE LATE-STAGE PEG INSERTION IN MND (15 November, 2016)

  Alexander Thompson, Victoria Blackwell, Rachael Marsden, Clare Lawson, Jeanette Brooks, Annabel H Nickol, Kevin Talbot, James E East, Philip Allan, Martin R Turner
• 006: A COMPARISON OF LUMBAR PUNCTURE WITH AND WITHOUT BEDSIDE ULTRASOUND (15 November, 2016)

  Stefan Williams, Modar Khalil, Richard Davey
• 007: CAUSES OF MORTALITY IN INDIVIDUALS WITH TUBEROUS SCLEROSIS COMPLEX (TSC) (15 November, 2016)

  Sam Amin, Andrew Lux, Nuala Calder, Matthew Laugharne, John Osborne, Finbar O'Callaghan
• 008: CLINICAL FEATURES, COURSE AND OUTCOMES OF PAEDIATRIC MOYAMOYA (15 November, 2016)

  Vijeya Ganesan, Sara Tho-Calvi, Dominic Thompson
• 009: CONTEMPORARY ANALYSIS OF MORTALITY IN MULTIPLE SCLEROSIS (15 November, 2016)

  Katharine Harding, Owain Williams, Mark Willis, Mark Wardle, Trevor Pickersgill, Neil Robertson
• 010: OCULAR PRESENTATION OF MYASTHENIA GRAVIS: AN AUDIT AND NATURAL HISTORY COHORT (15 November, 2016)

  Sivesh Kathir Kamarajah, Girija Sadalage, Jonathan Palmer, Helena Carley, Paul Maddison, Arulmaran Sivaguru
• 011: EFFECTS OF VASCULAR COMORBIDITY IN PARKINSON'S DISEASE (15 November, 2016)

  Diane M A Swallow, Naveed Malek, Katherine A Grosset, Michael A Lawton, Nin P Bajaj, Roger A Barker, Yoav Ben-Shlomo, David J Burn, Huw R Morris, Nigel Williams, Nicholas W Wood, Donald G Grosset, on behalf of the PRoBaND collaborators
• 012: LONG-TERM OUTCOMES IN MEDICALLY TREATED MOYAMOYA DISEASE (15 November, 2016)

  Angeliki Zarkali, Nicholas Brown, Nicola Harding, Joan Grieve, Matthew Adams, Vijeya Ganesan, Robert Simister, Martin Brown
• 013: GENETIC MODIFIERS OF HUNTINGTON'S DISEASE PROGRESSION (15 November, 2016)

  Davina Hensman Moss, Antonio Pardiñas, Michael Flower, James Miller, Kitty Lo, Vincent Plagnol, Peter Holmans, Lesley Jones, Douglas Langbehn, Sarah Tabrizi
• 014: THE ANDRO-METABOLIC SIGNATURE OF IIH COMPARED WITH PCOS AND SIMPLE OBESITY (15 November, 2016)

  Catherine Hornby, Michael O'Reilly, Hannah Botfield, Keira Markey, Punith Kempegowda, Angela Taylor, Beverley Hughes, Jeremy Tomlinson, Wiebke Arlt, Alexandra Sinclair
• 015: DISRUPTION TO THE DOPAMINERGIC SYSTEM AFTER TRAUMATIC BRAIN INJURY (15 November, 2016)

  Peter O Jenkins, Sara De Simoni, Jessica Fleminger, Niall Bourke, Amy Jolly, James Cole, Daniel Darian, David Sharp
• 016: A NOVEL MODEL OF GBA1-ASSOCIATED PARKINSON'S DISEASE IMPLICATES AUTOPHAGY (15 November, 2016)

  Kerri Kinghorn, Sebastian Gronke, Jorge Ivan Castillo-Quan, Li Li, Nathaniel Woodling, Ernestas Sirka, Matt Gegg, John Hardy, Linda Partridge
• 017: IMPAIRED MSC-MEDIATED NEUROGLIAL PROTECTION IN PROGRESSIVE MS (15 November, 2016)

  Pamela Sarkar, Juliana Redondo, Kevin Kemp, Alastair Wilkins, Neil Scolding, Claire Rice
• 018: LONG-TERM FORGETTING IN PRECLINICAL FAMILIAL ALZHEIMER'S DISEASE (15 November, 2016)

  Philip Weston, Yuying Liang, Susie Henley, Jennifer Nicholas, Natalie Ryan, Jonathan Schott, Martin Rossor, Christopher Butler, Adam Zeman, Nick Fox
• 019: FLORBETAPIR IMAGING IN CLINICAL PRACTICE: A RETROSPECTIVE STUDY OF 100 PATIENTS (15 November, 2016)

  Christopher Carswell, Kirsty Muckle, Adam Waldman, Zarni Win, Paresh Malhotra, Richard Perry
• 020: TIME TO USE MRI FOR RISK STRATIFICATION IN SYMPTOMATIC CAROTID STENOSIS? (15 November, 2016)

  Akram Hosseini, Richard Simpson, Nishath Altaf, Philip Bath, Shane MacSweeney, Dorothee Auer
• 021: CT PREDICTORS OF MALIGNANT MIDDLE CEREBRAL ARTERY INFARCTION (15 November, 2016)

  Rachael McAughtrie, Bharath Kumar Cheripelli, Fiona Catherine Moreton, Xuya Huang, Dheeraj Kalladka, Niall MacDougall, Ferghal McVerry, Keith Muir
• 022: WHAT DO DIAGNOSTIC TESTS TELL US IN CENTRAL NERVOUS SYSTEM VASCULITIS? (15 November, 2016)

  Ferghal McVerry, Keith Muir, Mark McCarron
• 023: PUPILLARY REWARD SENSITIVITY IS A MARKER OF APATHY IN PARKINSON'S DISEASE (15 November, 2016)

  Kinan Muhammed, Michael Ben Yehuda, Daniel Drew, Sanjay Manohar, Trevor Chong, George Tofaris, Marko Bogdanovic, Graham Lennox, Michele Hu, Masud Husain
• 024: CORRELATION OF CLINICAL AND MOLECULAR FEATURES IN MYOTONIC DYSTROPHY TYPE 1 (15 November, 2016)

  Saam Sedehizadeh, J David Brook, Paul Maddison
• 025: ‘RAPID PUSH’ SCIG – A REVIEW OF 20 PATIENTS (15 November, 2016)

  Michael Cumberbatch, Amanda Cox
• 026: INTERDISCIPLINARY CONSENUS ON THE MANAGEMENT OF IIH IN THE UK (15 November, 2016)

  Ghaniah Hassan-Smith, Susan Mollan, Brendan Davies, Simon Shaw, Bhawisha Swarupsinh Chavda, Anita Krishnan, Conor Mallucci, Nicholas Silver, Benjamin Wakerley, Alexandra Sinclair
• 027: IMPLICATIONS OF ANTI-CN1A SEROTYPE IN INCLUSION BODY MYOSITIS (15 November, 2016)

  James Lilleker, Anke Rietveld, Stephen Pye, Janine Lamb, Mark Roberts, Robert Cooper, Ger Pruijn, Hector Chinoy, Baziel van Engelen, MYONET Collaborators
• 028: THE UK RISK SHARING SCHEME: FINAL 10 YEAR ANALYSIS (15 November, 2016)

  Jacqueline Palace, Martin Duddy, Thomas Bregenzer, Benjamin Piske, Michael Lawton, Feng Zhu Joel, Oger Helen Tremlett, Mike Boggild, Neil Robertson, Richard Lilford, Kate Tilling, Yoav Ben-Shlomo, Claire Potter, Charles Dobson
• 029: PATISIRAN PH 2 OPEN-LABEL EXTENSION STUDY IN FAMILIAL AMYLOIDOTIC POLYNEUROPATHY (15 November, 2016)

  Hartmut Schmidt, David Adams, Teresa Coelho, Isabel Conceicao, Marcia Waddington-Cruz, Juan Buades, Josep Campistol, Jean Pouget, Jared Gollob, Ole Suhr
• 030: THE EFFECT OF MINOCYCLINE ON NEUROINFLAMMATION AFTER BRAIN TRAUMA (15 November, 2016)

  Gregory Scott, Amy Jolly, Peter O Jenkins, Anne Lingford-Hughes, Maneesh Patel, Anthony Goldstone, Paul Matthews, David Sharp
• 031: THE PHANTOM MENACE (15 November, 2016)

  Josh Fulton, John Williamson, Kumar Das, Mark Doran
• 032: IMAGING IN DEMENTIA (15 November, 2016)

  W Richard Bevan-Jones, Franklin Aigbirhio, Luca Passamonti, Tim Fryer, Yong Hong, Jonathan Coles, John O'Brien, James Rowe
• 033: A PERPLEXING PLEXOPATHY (15 November, 2016)

  Heba Madi, Claire Gall, Peter Flegg
• 034: HICKAM'S DICTUM VERSUS OCKHAM'S RAZOR (15 November, 2016)

  R Marchant, E Bunting, AW Barritt, CD Good, N Adams, A Merve, MM Wickremaratchi
• 035: KEEP YOUR HEAD DOWN AND SHAKE (15 November, 2016)

  Girija Sadalage, Muhammad Yousaf, Saiju Jacob
• 036: IF THE SHOE DOESN'T FIT, DON'T WEAR IT (15 November, 2016)

  Senthilkumar Vijayarangam Shanmugam, Pawanjit Minhas, Paul Johns, Khaled Abdel-Aziz
• 037: ATYPICAL GUILLAIN-BARRé IN THREE MONTHS IN SOUTH EAST WALES (15 November, 2016)

  Bradley Arms-Williams, Chris Woodward, Rhys Thomas, Gareth Payne, Benny Thomas, Janet Ann Johnston, Trevor Pickersgill
• 038: PARANEOPLASTIC ANTI-GQ1B SYNDROME ASSOCIATED WITH DIFFUSE LARGE B-CELL LYMPHOMA (15 November, 2016)

  Ruth Robinson, Jan Coebergh, Khaled Abdel-Aziz
• 039: NORSE ASSOCIATED WITH ANTI-GLYCINE RECEPTOR ANTIBODIES (15 November, 2016)

  Ruth Robinson, Rod Hughes, Adrian Fowle, Khaled Abdel-Aziz
• 040: NON-CONVULSIVE STATUS EPILEPTICUS ON THE ACUTE MEDICAL UNIT (15 November, 2016)

  Guleed Adan, Ashik Babu, Michael Bonello, Omar Siddiqi, Tom Solomon, Benedict Daniel Michael
• 041: THE ACUTE COMPLICATIONS OF MELAS: A CASE SERIES (15 November, 2016)

  Nicole Bramhall, Matthew Jones
• 042: CEREBRAL AMYLOID ANGIOPATHY-RELATED INFLAMMATION: A COMPLEX CASE (15 November, 2016)

  Oliver Cousins, Bhavini Patel, Usman Khan
• 043: FEMORAL NEUROPATHY FROM ILIACUS HAEMATOMA AS FIRST PRESENTATION OF HAEMOPHILIA (15 November, 2016)

  Janev Fehmi, Catherine Morgan
• 044: INTER-PROFESSIONAL NEUROLOGY SIMULATION TRAINING (15 November, 2016)

  Clare Galtrey, Bhavini Patel, Jessica Styles, Niran Nirmalananthan, Anthony Pereira
• 045: “CRYPTOGENIC DROP ATTACKS” REVISITED (15 November, 2016)

  Ingrid Hoeritzauer, Alan Carson, Jon Stone
• 046: ARE NEUROLOGISTS MISSING THE POINT? (15 November, 2016)

  Robert Hurford, Cara Bhuller, Liz Bright, Francesca Crawley
• 047: THE ESSENTIAL NEUROLOGICAL EXAMINATION FOR ACUTE PHYSICIANS (15 November, 2016)

  Matthew Jones
• 048: SERVICE PROVISION FOR CEREBRAL VENOUS SINUS THROMBOSIS. A UK SURVEY (15 November, 2016)

  Tim Lavin, Martin Punter, Mark Holland
• 049: AN INCIDENTAL DUMBBELL PRANG? (15 November, 2016)

  Patrick Moloney, Maeve Bradley, Eimear Maloney, Sean O' Riordan, Sean Connolly, Christopher McGuigan
• 050: DESCRIPTIONS OF BACK PAIN REVEAL UNDERLYING PATHOLOGY BEHIND ACUTE MENINGITIS (15 November, 2016)

  Catherine Morgan, Geraint Fuller
• 051: ACUTE NEUROLOGY SERVICE-2 YEAR STUDY SHOWING IMPACT OF A DGH NURSE COORDINATOR (15 November, 2016)

  Ajay Boodhoo, Reza Motazed, Fred Schon, Arani Nitkunan
• 052: DIABETIC POLYRADICULONEUROPATHY PRESENTING WITH MYOCLONUS (15 November, 2016)

  Emily Pegg, Riffat Tanveer, Godwin Lekuwwa, Roger Mills, Hedley Emsley
• 053: MEASUREMENT OF FORCED VITAL CAPACITY (FVC) IN ACUTE NEUROMUSCULAR WEAKNESS (15 November, 2016)

  Anna Randall, Baba Aji
• 054: A CASE OF THE ‘SEVERAL-YEAR ITCH’ (15 November, 2016)

  Christopher Woodward, Ray Wynford-Thomas, Mark Wardle
• 055: CONVERSATION ANALYSIS IN THE MEMORY CLINIC (15 November, 2016)

  Daniel Blackburn, Chris Elsey, Kirsty Harkness, Sarah Wakefield, Annalena Venneri, Paul Drew, Markus Reuber
• 056: QEEG CAN DISTINGUISH PATIENTS WITH AD AND VOLUNTEERS (15 November, 2016)

  Daniel Blackburn, Zhou Yifan, Simon Bell, Matteo De Marco, Fei He, Iain Wilkinson, Thomas Farrow, Annalena Venneri, Ptolemaios Sarrigiannis
• 057: EXPECTATION AND REWARD IN DEMENTIA: THE CASE OF MUSIC (15 November, 2016)

  Camilla Clark, Hannah Golden, Oliver McCallion, Jennifer Nicholas, Miriam Cohen, Catherine Mummery, Jonathan Schott, Jason Warren
• 058: DTI SEGMENTATION IN FOCAL CORTICAL NEURODEGENERATIVE SYNDROMES (15 November, 2016)

  Natasha Clarke, Thomas Barrick, Peter Garrard
• 059: KCNJ11 MUTATIONS CAUSE SEVERE NEUROPSYCHOLOGICAL DEFICITS (15 November, 2016)

  Jacob Day, Lorna Torrens, Pamela Bowman, Maggie Shepherd, Ali Chakera, Andrew Hattersley, Adam Zeman
• 060: THE ROLE OF HIPPOCAMPAL PATHOLOGY IN POST-STROKE COGNITIVE IMPAIRMENT (15 November, 2016)

  Akram A Hosseini, Sissi Ispoglou, Tom Hayton, Rachel Evans, Martin Wilson, Vijay Sawlani, Pia Rotshtein, Dorothee P Auer
• 061: PROBING FTD GENETICS WITH NEXT-GENERATION SEQUENCING (15 November, 2016)

  Carolin Koriath, Gary Adamson, Ron Druyeh, Janna Kenny, Martin Rossor, Jon Schott, John Collinge, Nick Fox, Jon Rohrer, Simon Mead
• 062: M-ACE VERSUS MOCA: COMPARATIVE STUDY (15 November, 2016)

  AJ Larner
• 063: A COMMON MECHANISM UNDERLYING APATHY ACROSS NEUROLOGICAL DISORDERS (15 November, 2016)

  Campbell Le Heron, Sanjay Manohar, Kinan Muhammed, Dan Drew, Annie Blake, Matthew Jackson, Masud Husain
• 064: THE DE-CAFF STUDY: CAFFEINE IN COGNITIVE IMPAIRMENT (15 November, 2016)

  Kanchan Sharma, Greg Munro, Scott Ankrett, Thomas Davis, Elizabeth Coulthard
• 065: FIBROMYALGIA IN THE COGNITIVE DISORDERS CLINIC (15 November, 2016)

  John Williamson, Andrew Larner
• 066: SCORING ERRORS IN COGNITIVE SCREENING INSTRUMENTS ADMINISTERED IN PRIMARY CARE (15 November, 2016)

  Alex Wojtowicz, Andrew Larner
• 067: MONITORING THE THERAPEUTIC EFFECTS OF DECORIN IN HYDROCEPHALUS (15 November, 2016)

  Anuriti Aojula, Hannah Botfield, James Patterson McAllister, Ana Maria Gonzalez, Osama Abdullah, Ann Logan, Alexandra Sinclair
• 068: MIGRAINE IN KLEINE-LEVIN SYNDROME (15 November, 2016)

  Harry Donnelly, Guy Leschziner, Juana Marin, Alexander Nesbitt
• 069: EPIDEMIOLOGY OF CLUSTER HEADACHE IN A DGH HEADACHE CLINIC (15 November, 2016)

  Nicola Giffin
• 070: CHARACTERISING FAT DISTRIBUTION AND RESPONSE TO WEIGHT LOSS IN IIH (15 November, 2016)

  Catherine Hornby, Hannah Botfield, Michael O'Reilly, Keira Markey, William Scotton, Jeremy Tomlinson, Wiebke Arlt, Alexandra Sinclair
• 071: CHARACTERISATION OF THE PREMONITORY STAGE OF MIGRAINE IN PAEDIATRIC MIGRAINEURS (15 November, 2016)

  N Karsan, P Prabhakar, P J Goadsby
• 072: DISABILITY FROM POST-TRAUMATIC HEADACHE IS COMPOUNDED BY PTSD (15 November, 2016)

  Louise Roper, Peter Nightingale, Zhangjie Su, Antonio Belli, Alexandra Sinclair
• 073: GLUCAGON LIKE PEPTIDE-1 REDUCES RAISED INTRACRANIAL PRESSURE (15 November, 2016)

  Hannah Botfiled, Maria Ulhdall, James Mitchell, Snorre Hagen, Ana Maria Gonzalez, Rigmor Jensen, Alex Sinclair
• 074: MASS ON SCAN OR MASSON SCAN (15 November, 2016)

  Andrew W Barritt, Ashirwad Merve, Prasanna Epaliyanage, Julia Aram
• 075: PERAMPANEL TREATMENT FOR GENERALISED TONIC-CLONIC SEIZURES (15 November, 2016)

  Terence O'Brien, Anna Patten, Francesco Bibbiani, Haichen Yang, Betsy Williams, Antonio Laurenza
• 076: REAL-WORLD DATA ON ESLICARBAZEPINE ACETATE: THE EPOS STUDY (15 November, 2016)

  Martin Holtkamp, Rob McMurray, Rui Sousa, Edgar Kockelmann
• 077: REAL-WORLD DATA ON ESLICARBAZEPINE ACETATE IN ELDERLY PATIENTS (15 November, 2016)

  Camilla Karlsson, Rob McMurray, Rui Sousa, Martin Holtkamp
• 078: DIAGNOSIS IS KEY: ACUTE HOSPITAL MANAGEMENT OF NONEPILEPTIC SEIZURES (15 November, 2016)

  Sophie Fitzsimmons, Lisa Page, Julia Aram
• 079: SIMULTANEOUS EEG-FMRI AS A PRE-SURGICAL EVALUATION TOOL IN FOCAL EPILEPSY: A SYSTEMATIC REVIEW (15 November, 2016)

  Abdurrahman Islim, Graham Kemp
• 080: SYMPTOMS AND ACCEPTANCE OF PSYCHOGENIC NON-EPILEPTIC SEIZURES (15 November, 2016)

  Mark Thaller, Rohan Kandasamy, Michael Hyland, Martin Sadler
• 081: PREGNANCY IN WOMEN WITH EPILEPSY; CAN WE COMMUNICATE BETTER? (15 November, 2016)

  Elizabeth Lovegrove, Anirban Romi Saha
• 082: COMMON BUT RARE: A CASE OF LATE PRESENTATION DUE TO NEUROCYSTICERCOSIS (15 November, 2016)

  Elizabeth Mallam, Begoña Bovill, Howard Faulkner
• 083: THREE YEARS OF CHANGES IN VIDEO-EEG TELEMETRY SURVEILLANCE (15 November, 2016)

  Clare Oliver, Lliwen Jones, Ronak Ved, Glenn Brimble, Khalid Hamandi
• 084: MISSING A BEAT: AN ARRESTING, OVERLOOKED CAUSE OF SEIZURES (15 November, 2016)

  Guy Parsons
• 085: AN RCT OF SELF-MANAGEMENT EDUCATION IN EPILEPSY: PARTICIPANTS AT BASELINE (15 November, 2016)

  Leone Ridsdale, Laura Goldstein, Adam Noble, Mark Richardson, Stephanie Taylor, Emily Robinson, Gabriella Wojewodka, Sabine Landau
• 086: REAL-WORLD DATA ON IMPACT OF ESLICARBAZEPINE ACETATE ON QOL (15 November, 2016)

  Rob McMurray, Michael Kerr, Rui Sousa, Martin Holtkamp
• 087: ESLICARBAZEPINE ACETATE IN PREVIOUS CARBAMAZEPINE NON-RESPONDERS (15 November, 2016)

  Rob McMurray, Camilla Karlsson, Rui Sousa, Martin Holtkamp
• 088: PSYCHIATRIC/BEHAVIOURAL EVENTS WITH PERAMPANEL TREATMENT FOR PGTCS (15 November, 2016)

  Cindy Dobrinsky, Alan Ettinger, William Rosenfeld, Betsy Williams, Antonio Laurenza, Haichen Yang, Anna Patten, Francesco Bibbiani
• 089: ESLICARBAZEPINE ACETATE AS ADD-ON TO DIFFERENT AED MONOTHERAPIES (15 November, 2016)

  Philippe Derambure, Rob McMurray, Rui Sousa, Martin Holtkamp
• 090: IS EPILEPSY CARE IN LOW-GRADE GLIOMA PATIENTS MEETING BEST PRACTICE? (15 November, 2016)

  Freya Waite-Taylor, Tim Jones, Hannah Cock
• 091: EFFICACY AND ADVERSE EFFECTS OF ANTI EPILEPTIC DRUGS (15 November, 2016)

  Udo Wieshmann, Gus Baker
• 092: AUDIT ON SECOND LINE TREATMENT OF CONVULSIVE STATUS EPILEPTICUS (CSE) (15 November, 2016)

  Sue Lim, Ela Akay, Sumeet Singhal
• 093: SERUM BIOMARKERS FOR PARKINSON'S DISEASE (15 November, 2016)

  Fahd Baig, Greg Toulson, Michael Lawton, Samuel Evetts, Claudio Ruffmann, Michal Rolinski, Johannes Klein, Reza Morovat, Yoav Ben-Shlomo, Michele Hu
• 094: IMPROVING THE EXPERIENCE OF DIAGNOSIS IN PARKINSON'S DISEASE (15 November, 2016)

  Ben Blight, Jane Davis, Val Evans, Nicola Hawkes, Camille Carroll
• 095: VASCULAR DISEASE AND RISK ASSESSMENT IN PARKINSON'S DISEASE (15 November, 2016)

  Kelvin Cheng, Diane Swallow, Katherine Grosset, Donald Grosset
• 096: DEVELOPMENT AND VALIDATION OF A PROGNOSTIC MODEL OF MORTALITY IN PD (15 November, 2016)

  Angus Macleod, Ingvild Dalen, Ole-Bjørn Tysnes, Jan Petter Larsen, Carl Counsell
• 097: PD-TAP: AN OBJECTIVE AND AUTOMATED MEASURE OF PARKINSON'S DISEASE SEVERITY (15 November, 2016)

  Thea Dominey, Craig Newman, Camille Carroll, Rupert Noad, Benjamin Appleyard, Catherine Deeprose, Stephen Hall
• 098: RECURRENT HEMICHOREA AS A MARKER OF GLYCAEMIC CONTROL (15 November, 2016)

  A Drazyk, L Williams, R Killeen, J Kinsella, C McGuigan
• 099: COGNITIVE IMPAIRMENT OCCURS BEFORE LOSS OF FUNCTION IN ALS (15 November, 2016)

  Matt Gabel, Stella Tsermentseli, Laura H Goldstein, Ammar Al-Chalabi, Alexandra Young, Daniel Alexander, P. Nigel Leigh, Mara Cercignani
• 100: PROGNOSIS IN PARKINSON PLUS SYNDROMES – A SYSTEMATIC REVIEW (15 November, 2016)

  Stella Glasmacher, Romi Saha
• 101: NEW OBSERVATIONS ON THE TREATMENT OF LANCE ADAMS SYNDROME; A CASE REPORT (15 November, 2016)

  Omar Hussein, Himanshu Chokhawala, Eduardo Gonzalez-Toledo
• 102: PALATAL TREMOR: 12 CASES-THE EXPERIENCE OF A TERTIARY NEUROSCIENCE CENTRE (15 November, 2016)

  Nazia Karsan, Pablo Garcia Reitboeck, Christian Lambert, Salah Omer
• 103: THE CLINICAL FEATURES OF FUNCTIONAL (PSYCHOGENIC) EYE MOVEMENTS (15 November, 2016)

  Diego Kaski, Vidushi Pradhan, Adolfo Bronstein
• 104: CREATIVITY & IMPULSIVITY: PAINTING A PICTURE OF DOPAMINE THERAPY IN PARKINSON'S (15 November, 2016)

  Mark Kelly, Fahd Baig, David Okai, Michele Hu
• 105: BONE HEALTH IN PARKINSONISM: A QUALITY IMPROVEMENT PROJECT (15 November, 2016)

  Lydia Silvester, Christopher Kobylecki
• 106: CORTICOBASAL SYNDROME AND CORTICOBASAL DEGENERATION (15 November, 2016)

  Ruth Lamb, Marcia Darvell, John Woodside, Jon Rohrer, Andrew Lees, Huw Morris
• 107: NEUROMELANIN-SENSITIVE RESONANCE IMAGING AS A PARKINSON'S DISEASE BIOMARKER (15 November, 2016)

  Antonio Martin-Bastida, Stefan Schwarz, Yue Xing, Sara Pietracupa, David Burn, Monty Silverdale, Nin Bajaj, Donald Grosset, Dorothee Auer, Piccini Paola
• 108: COMPARING STIMULUS-PRESENTATION METHODS IN TEMPORAL DISCRIMINTATION TESTING (15 November, 2016)

  Eavan McGovern, John Butler, Ines Beiser, Laura Williams, Brendan Quinlivan, Sean O Riordan, Richard Reilly, Michael Hutchinson
• 109: AN UNUSUAL CAUSE OF PARKINSONISM (15 November, 2016)

  John McAuley, Gaenor Hughes
• 110: IMPROVING PROVISION OF PARKINSON'S DISEASE EXERCISE CLASSES (15 November, 2016)

  Priyanka Pujara, Jane Rideout, Camille Carroll
• 111: PROGRESSIVE SUPRANUCLEAR PALSY IN THE ELDERLY IN A DISTRICT GENERAL HOSPITAL (15 November, 2016)

  Hafeez Rajwani, Jan Coebergh
• 112: DEEP PHENOTYPING OF THE G2019S LRRK2 MUTATION IN PARKINSON'S DISEASE: UCL COHORT (15 November, 2016)

  Mie Rizig, Hallgeir Jonvik, Thomas Foltynie, Patricia Limousin, Kailash Bhatia, Thomas Warner, Huw Morris, Nicholas Wood
• 113: LEVODOPA-INDUCED DYSKINESIA IN PARKINSON'S: A LONGITUDINAL PET STUDY (15 November, 2016)

  Andreas-Antonios Roussakis, Nicholas Lao-Kaim, Antonio Martin-Bastida, Natalie Valle-Guzman, Zinovia Kefalopoulou, Gesine Paul-Visse, Hakan Widner, Marios Politis, Tom Foltynie, Roger Barker, Paola Piccini
• 114: CHANGE IN VISUAL FUNCTION IN PARKINSON'S DISEASE (15 November, 2016)

  Rimona S Weil, Katerina Pappa, Hannah Burn, Ivanna Pavisic, Sam Schwarzkopf, Jason Warren, Huw Morris
• 115: DNA REPAIR PATHWAYS MODULATE ONSET IN POLYGLUTAMINE DISEASES (15 November, 2016)

  Conceição Bettencourt, Davina Hensman Moss, Michael Flower, Sarah Wiethoff, Paola Giunti, Alexandra Durr, Peter Holmans, Henry Houlden, Sarah Tabrizi, Lesley Jones
• 116: PARKINSON'S FAMILIES PROJECT: RECRUITMENT OF FAMILIAL PD PATIENTS VIA THE BNSU (15 November, 2016)

  James Hong, Manuela Tan, Mie Rizig, Concetta Brugaletta, Sarah Cable, Steven Lubbe, Huw Morris
• 117: RARE STRUCTURAL GENETIC VARIATION IN HUMAN PRION DISEASES (15 November, 2016)

  Ana Lukic, James Uphill, CA Brown, Jon Beck, Mark Poulter, Tracey Campbell, Gary Adamson, Holger Hummerich, John Collinge, Simon Mead
• 118: THE EXPERIENCE OF THE FIRST ADULT NEUROGENETIC CLINIC IN IRELAND (15 November, 2016)

  Diana Olszewska, Terri McVeigh, Tim Lynch
• 119: UK PATIENT PREFERENCE FOR CHARACTERISTICS OF DMTS IN MS (15 November, 2016)

  Catherine Bottomley, Sheetal Padania, Andrew Lloyd, Bennett Gary, Colin Green, Nicholas Adlard
• 120: ‘TRIMMING’ THE DIAGNOSIS (15 November, 2016)

  Wail Ahmed, Liam Stuart Carroll, James Samuel Coe, Waqar Rashid, Bunting Eva
• 121: TREATING MULTIPLE SCLEROSIS WITH CLADRIBINE (15 November, 2016)

  C Alvarez-Gonzalez, K Allen-Philbey, J Mathews, BP Turner, D Baker, S Gnanapavan, M Marta, G Giovannoni, K Schmierer
• 122: NEUROMYELITIS OPTICA IN HIV: A CASE REPORT AND LITERATURE REVIEW (15 November, 2016)

  Jason P Appleton, Anthony Kenton
• 123: EVIDENCE FOR MS SERVICES: FINDINGS OF THE MS TRUST'S GEMSS PROGRAMME (15 November, 2016)

  Amy Bowen, Geraldine Mynors, Jane Suppiah
• 124: RECURRENT MILLER FISHER SYNDROME IN ADULTS: A CASE REPORT AND LITERATURE REVIEW (15 November, 2016)

  Jacob Brolly, John Paul Leach
• 125: ALEMTUZUMAB PERSISTENTLY SLOWS BRAIN VOLUME LOSS IN RRMS (15 November, 2016)

  Alasdair Coles, Douglas Arnold, Frederik Barkhof, Massimo Filippi, Hans-Peter Hartung, Eva Havrdova, Krzysztof Selmaj, David Margolin, Karthinathan Thangavelu, Sven Schippling, on behalf of the CARE-MS I and CARE-MS II Investigators
• 126: ENCEPHALITIS: PARENCHYMAL LEUCOCYTES IN INFECTIOUS, IMMUNE AND UNKNOWN CAUSE (15 November, 2016)

  O Daramola, N Rathi, BD Michael, MJ Griffiths, N Moxham, L Benjamin, D Crooks, T Solomon
• 127: THE BURDEN OF BLADDER DYSFUNCTION IN MULTIPLE SCLEROSIS: A MULTI-CENTRE AUDIT (15 November, 2016)

  Angharad Davis, Benjamin Turner, Malik Ramadhan, Christo Albor, Klaus Schmierer, Gavin Giovannoni
• 128: RECRUITMENT IN MULTIPLE SCLEROSIS TRIALS: THE MS-SMART EXPERIENCE (15 November, 2016)

  Jeremy Chataway, Siddharthan Chandran, David Miller, Peter Connick, Gavin Giovannoni, Sue Pavitt, Nigel Stallard, Clive Hawkins, Basil Sharrack
• 129: EXPLORING COGNITION IN SECONDARY PROGRESSIVE MULTIPLE SCLEROSIS (SPMS) (15 November, 2016)

  Anisha Doshi, Domenico Plantone, Floriana DeAngelis, Claudia Wheeler-Kingshott, Olga Ciccarelli, Jeremy Chataway
• 130: COMPLICATION RATES OF IVIG IN INFLAMMATORY NEUROPATHY (15 November, 2016)

  Kariem Elhadd, Sidra Khan, David Gosal, Amanda Woodall, Eman Nasr, Nazar Sharaf
• 131: LAMBERT-EATON MYASTHENIC SYNDROME IN A TERTIARY NEUROLOGY CENTRE (15 November, 2016)

  Mark Ellul, Michael Bonello, Udo Wieshmann
• 132: ALEMTUZUMAB IMPROVES EDSS FUNCTIONAL SYSTEMS SCORES IN RRMS (15 November, 2016)

  Gavin Giovannoni, Regina Berkovich, Oscar Fernandez, Heinz Wiendl, David Margolin, Karthinathan Thangavelu, Christopher LaGanke, on behalf of the CARE-MS I and CARE-MS II Investigators
• 133: THE ASSOCIATION OF HLA-DRB1*1501 AND DISABILITY IN MULTIPLE SCLEROSIS (15 November, 2016)

  Katharine Harding, James Hrastelj, Samantha Loveless, Neil Robertson
• 134: NEW INSIGHTS ON NEUROMYELITIS OPTICA (15 November, 2016)

  Omar Hussein, Christian Cajavilca, Raghav Aachi, Alireza Minagar
• 135: SEIZURES AND CORTICAL LESIONS IN MOG IgG ASSOCIATED SYNDROMES (15 November, 2016)

  Shahd Hamid, Mariyam Saviour, Kerry Much, Liene Elsone, Maneesh Bhojak, Anu Jacob
• 136: A NEW SYMPTOM IN NEUROLOGY: NEUROPATHIC POST-EJACULATORY PAIN IN NMO (15 November, 2016)

  Anu Jacob, Samia Elkommos, Shahd Hamid, Kerry Mutch, Jalesh Panicker, Bernhard Frank, Liene Elsone, Turo Nurmikko
• 137: RITUXIMAB USE IN A PATIENT WITH ANTI-RI POSITIVE OPSOCLONUS MYOCLONUS SYNDROME (15 November, 2016)

  Girija Sadalage, John Bowen, Simon Nightingale, Saiju Jacob
• 138: A NOVEL MONITORING SYSTEM FOR HYPOTHERMIA IN MULTIPLE SCLEROSIS: A CASE STUDY (15 November, 2016)

  Stephe Kamalathasan, Helen Ford
• 139: NATALIZUMAB REDUCES MS RELAPSE RATES IN UK TOP PATIENTS (15 November, 2016)

  Richard Nicholas, Jerome Hanna
• 140: DACLIZUMAB HYP VS IM INTERFERON BETA-1A IN MS: NEDA RESULTS FROM DECIDE (15 November, 2016)

  Ludwig Kappos, Eva Havrdova, Gavin Giovannoni, Bhupendra Khatri, Steven Greenberg, Ping Wang, Jacob Elkins, Giorgio Giannattasio
• 141: DACLIZUMAB HYP IN MULTIPLE SCLEROSIS: 3-YEAR RESULTS FROM SELECTED (15 November, 2016)

  Ernst-Wilhelm Radue, Gavin Giovannoni, Ralf Gold, Krzysztof Selmaj, Eva Havrdova, Dusan Stefoski, Till Sprenger, Xavier Montalban, Kathy Riester, Gulden Ozen
• 142: THE NEWCASTLE EXPERIENCE OF ANTI-MOG ASSOCIATED DISEASE (15 November, 2016)

  Clare Bolton, James Chapman, David Ledingham, David Lewis-Smith, Achillefs Spyropoulos, Joe Guadagno, Martin Duddy
• 143: OCRELIZUMAB IN PRIMARY PROGRESSIVE MS: THE ORATORIO STUDY (15 November, 2016)

  G Giovannoni, DL Arnold, A Bar-Or, J de Seze, B Hemmer, X Montalban, K Rammohan, J Wolinsky, on behalf of the ORATORIO clinical investigators
• 144: OCRELIZUMAB VS INTERFERON β-1A IN RELAPSING MS: TWO STUDIES (15 November, 2016)

  E Silber, DL Arnold, A Bar-Or, G Comi, HP Hartung, SL Hauser, F Lublin, K Selmaj, A Traboulsee, L Kappos, on behalf of the OPERA I and II clinical investigators
• 145: CAN LIQUORICE MAKE STEROIDS MORE PALATABLE IN MULTIPLE SCLEROSIS? (15 November, 2016)

  Samantha Low, Jeremy Chataway
• 146: COMPLEMENT ACTIVATION IN MULTIPLE SCLEROSIS AND NMO SPECTRUM DISORDERS (15 November, 2016)

  Sebastian Luppe, Svetlana Hakobyan, David Evans, Katherine Harding, Sam Loveless, Neil Robertson, B. Paul Morgan
• 147: USAGE AND EQUITABILITY OF MULTIPLE SCLEROSIS DMT IN ENGLAND (15 November, 2016)

  Roger Mills, Carolyn Young, on behalf of TONiC Investigators
• 148: INTRACEREBRAL HAEMORRHAGE IN NORMOTENSIVE PATIENT WITH PROBABLE NEUROSAROIDOSIS (15 November, 2016)

  Farhat Mirza, Joyutpal Das, Vanisha Chauhan, Paul Cooper, Adrian Pace
• 149: GILENYA PATIENT CHARACTERISTICS IN THE UK (15 November, 2016)

  Gordon Mazibrada, Paula Pamies Garcia-Ganuza
• 150: MS FINE STUDY: GILENYA REAL WORLD EXPERIENCE IN THE UK (15 November, 2016)

  Gordon Mazibrada, Paula Pamies Garcia-Ganuza
• 151: D-MANNOSE TO PREVENT URINARY TRACT INFECTIONS IN MULTIPLE SCLEROSIS (15 November, 2016)

  Jalesh Panicker, Véronique Phé, Mahreen Pakzad, Collette Haslam, Gwen Gonzales, Carmel Curtis, Bernadette Porter, Jeremy Chataway
• 152: METFORMIN CAN LEAD TO FUNCTIONAL VITAMIN B12 DEFICIENCY (15 November, 2016)

  Daniela Petrova, Mushtaqur Rahman, Vinod Devalia, Tabish Saifee
• 153: THE MS-SMART TRIAL IN SECONDARY PROGRESSIVE MS – CURRENT UPDATE (15 November, 2016)

  Jeremy Chataway, Siddharthan Chandran, David Miller, Peter Connick, Gavin Giovannoni, Sue Pavitt, Nigel Stallard, Clive Hawkins, Basil Sharrack, Domenico Plantone
• 154: CNS DEMYELINATION IN PATIENTS ON NILOTINIB TREATMENT FOR CML (15 November, 2016)

  Elissa Rekhi, Angharad Pryce, Mamta Sohal, Pooja Dassan
• 155: PREGNANCY OUTCOMES IN ALEMTUZUMAB-TREATED PATIENTS WITH RRMS (15 November, 2016)

  David Rog, Christina Chambers, Pamela McCombe, Susana Otero, Kerstin Hellwig, David Margolin, Karthinathan Thangavelu, Jiwon Oh, on behalf of the CAMMS223 CARE-MS I and CARE-MS II Investigators
• 156: USE OF PLASMA EXCHANGE FOR NEUROLOGICAL INDICATIONS (15 November, 2016)

  Girija Sadalage, Nicola Yoganayagam, Saiju Jacob
• 157: TUMEFACTIVE REBOUND OF MULTIPLE SCLEROSIS FOLLOWING CESSATION OF FINGOLIMOD (15 November, 2016)

  Sharfaraz Salam, Daniel Dunbar, Tim Lavin, Adrian Pace, Tatiana Mihalova
• 158: TRANSIENT NEUTROPENIA FOLLOWING INTRAVENOUS ALEMTUZUMAB TREATMENT (15 November, 2016)

  Sharfaraz Salam, Daniel Dunbar, Fran Jackson, Tim Lavin, Adrian Pace, Tatiana Mihalova
• 159: A PROSPECTIVE STUDY USING 3T T2* MRI PREDICTS MS IN UNCERTAIN CASES (15 November, 2016)

  Amal Samaraweera, Matthew South, Alain Pitiot, Chris Tench, Robert Dineen, Paul Morgan, Nikos Evangelou
• 160: REAL WORLD EXPERIENCE OF FINGOLIMOD IN MULTIPLE SCLEROSIS: THE LONDON AUDIT (15 November, 2016)

  Maria Stavrou, Deborah Smith, Pauline Shaw, Dominika Raciborska, Eli Silber, Peter Brex, Gavin Giovannoni, Klaus Schmierer, Benjamin Turner
• 161: NEUROMYELITIS OPTICA SPECTRUM DISORDER: A DECADE TO GET A DIAGNOSIS THAT FITS (15 November, 2016)

  Vahini Janarthen, Graham Warner
• 162: VSN16R – A NOVEL TREATMENT FOR SPASTICITY IN EXPERIMENTAL MULTIPLE SCLEROSIS (15 November, 2016)

  Thomas Williams, Gareth Pryce, Gavin Giovannoni, David Selwood, David Baker
• 163: THYROID AUTOIMMUNITY FOLLOWING ALEMTUZUMAB TREATMENT FOR MS (15 November, 2016)

  Sarah Healy, Taha Nasser, Mark Willis, Ilaria Muller, Katharine Harding, Trevor Pickersgill, Mark Wardle, Colin Dayan, Neil Robertson
• 164: REAL-WORLD LONG TERM OUTCOMES IN NATALIZUMAB TREATED PATIENTS (15 November, 2016)

  Ray Wynford-Thomas, Helen Owen, Sue Mulloch, Peter Evans, Bernie Conway, Lynne Watson, Owen Pearson
• 165: MEG REVEALS SPEECH PROCESSING DELAY IN PROGRESSIVE NON FLUENT APHASIA (15 November, 2016)

  Thomas Cope, Ediz Sohoglu, Karalyn Patterson, Catherine Dawson, Manon Grube, William Sedley, Matt Davis, James Rowe
• 166: THE PHENOTYPE OF PREMONITORY SYMPTOMS AND MIGRAINE HEADACHE TRIGGERED WITH NITROGLYCERIN (15 November, 2016)

  N Karsan, P Bose, JT Lowe, PJ Goadsby
• 167: THE ROLE OF ADAPTIVE IMMUNITY IN PARKINSONIAN SYNDROMES (15 November, 2016)

  James Varley, Angela Vincent, Sarosh Irani
• 168: ADRENERGIC SIGNALLING AND CONGENITAL MYASTHENIC SYNDROMES (15 November, 2016)

  Grace McMacken, Hanns Lochmuller
• 169: THE CLINICAL FEATURES AND PROGNOSIS OF SCAN NEGATIVE URO-NEUROLOGICAL DISORDERS (15 November, 2016)

  Ingrid Hoeritzauer, Jalesh Panicker, Sohier Elneil-Coker, Voula Granitsiotis, Doug Small, Patrick Statham, David Summers, Maria Eugenicos, Alan Carson, Jon Stone
• 170: ADULT-ONSET NEURONAL CEROID LIPOFUSCINOSIS (KUFS DISEASE) (15 November, 2016)

  Emeka Chuks Okonji
• 171: THE ROLE OF NUMERICAL COGNITION IN SOCIAL DECISION-MAKING (15 November, 2016)

  Sanjeev Ramachandran
• 172: CHRONIC DIZZINESS POST TRAUMATIC BRAIN INJURY: A CROSS-SECTIONAL STUDY (15 November, 2016)

  Hena Ahmad, Qadeer Arshad, Richard Roberts, Mitesh Patel, Timothy Ham, David Sharp, Barry Seemungal
• 173: CORRELATION ANALYSIS OF NEURITE ORIENTATION DISPERSION & DENSITY IMAGING IN MND (15 November, 2016)

  Rebecca Broad, Matthew Gabel, Nicholas Dowell, Gary Zhang, Daniel Alexander, Mara Cercignani, Peter Nigel Leigh
• 174: LIMB GIRDLE SYNDROMES: MYASTHENIA OR MYOPATHY (15 November, 2016)

  Pedro Rodriguez Cruz, Katsiaryna Belaya, Judy Cossins, Wei Wei Liu, Susan Maxwell, Richard Petty, Maria Farrugia, Timothy Walls, David Beeson, Jacqueline Palace
• 175: CAN'T RAISE ONE EYE BROW: DOES IT RING ANY NORWEGIAN BELLS? (15 November, 2016)

  Clare Galtrey, Fred Schon, Hamid Modarres, Alexander Rossor, Diana Lockwood, Mary Reilly, Hadi Manji
• 176: PRECIPITOUS LATE-ONSET RADIATION-INDUCED MYOPATHY (15 November, 2016)

  James Hong, Aisling Carr, Sachit Shah, Emma Matthews, Doreen Fiahlo, Helen Devine, Michael Hanna
• 177: PROXIMAL MYOTONIC DYSTROPHY MIMICKING PROGRESSIVE MUSCLE WASTING (15 November, 2016)

  Akram A. Hosseini, Sangeeta Chaal, Carl Mann
• 178: TUBULAR AGGREGATES AND CYLINDRICAL SPIRALS IN AUTOIMMUNE LIMB-GIRDLE MYASTHENIA (15 November, 2016)

  Girija Sadalage, Saiju Jacob
• 179: SURVEY OF PREGNANCY IN CHARCOT MARIE TOOTH DISEASE PATIENTS (15 November, 2016)

  Matilde Laura, Mariola Skorupinska, Karen Bull, Bridgette Byrne, Mary Reilly
• 180: MANAGING ORTHOPAEDIC COMPLICATIONS IN CHARCOT MARIE TOOTH DISEASE (15 November, 2016)

  Matilde Laura, Gita Ramdharry, Dishan Singh, Mariola Skorupinska, Mary Reilly
• 181: TIBIALIS ANTERIOR MUSCLE BIOPSY – A PATIENT REPORTED OUTCOME STUDY (15 November, 2016)

  James Lilleker, Amanda Woodall, Mark Roberts, Hector Chinoy
• 182: CHARACTERISATION OF UK ANTI-HMGCR+ ANTIBODY ASSOCIATED MYOSITIS (15 November, 2016)

  Sean Murphy, James Lilleker, Simon Rothwell, Zoe Betteridge, Neil McHugh, Mark Roberts, Janine Lamb, Robert Cooper, Hector Chinoy
• 183: DIABETIC LUMBOSACRAL RADICULOPLEXUS NEUROPATHY (DLSRN) AFTER BARIATRIC SURGERY (15 November, 2016)

  Antoinette O' Connor, Brian McNamara, Brian Sweeney
• 184: TRANSITION FOR NEUROMUSCULAR DISEASE (15 November, 2016)

  Ros Quinlivan
• 185: WHAT INFLUENCES FALSE POSITIVE ACHR ANTIBODY RESULTS? (15 November, 2016)

  Girija Sadalage, Pravin Torane, Abid Karim, Saiju Jacob
• 186: A PROSPECTIVE CLINICAL AND IMMUNOLOGICAL STUDY OF LATE ONSET MYASTHENIA GRAVIS (15 November, 2016)

  Girija Sadalage, Saiju Jacob, David Hilton-Jones, Camilla Buckley, Angela Vincent, Paul Maddison
• 187: HAEMOLYTIC ANAEMIA AS A COMPLICATION OF INTRAVENOUS IMMUNOGLOBULIN THERAPY (15 November, 2016)

  Sharfaraz Salam, Amanda Woodall, David Gosal
• 188: MANAGEMENT OF MYASTHENIA GRAVIS COMPARED TO NATIONAL GUIDELINES  (15 November, 2016)

  Pulukkuttiralalage Senali Perera, May Yung Tiet, Saiju Jacob
• 189: SEVERELY ELEVATED CREATINE KINASE IN A CASE OF GIULLAIN-BARRÉ SYNDROME (15 November, 2016)

  Philip Weston, Jan Coebergh, Ian White
• 190: OPTIMISING IVIG DELIVERY IN A TERTIARY NEUROLOGY CENTRE (15 November, 2016)

  Angeliki Zarkali, Guendalina Bonifacio, Christina Englezou, Victoria Van Hamel Parsons, Hanna Renshaw, Gordon Ingle, Hadi Manji, Mary Reilly, Michael Lunn, Aisling Carr
• 191: CLL, A RARE BUT TREATABLE CAUSE OF LONGITUDINALLY EXTENSIVE MYELITIS (15 November, 2016)

  Wail Ahmed, James Coe, Liam Carroll, S Vundavalli, Timothy Chevassut, Romi Saha
• 192: AUDIT OF INCIDENTAL PINEAL CYSTS INVESTIGATION IN A DISTRICT GENERAL HOSPITAL (15 November, 2016)

  Omar AlMasri, Emily Russell, Catherine O'Brien, Sonali Dharia, Gareth Smith, Jonathan Stewart, Brendan McLean
• 193: PRIMARY T-CELL CNS LYMPHOMA MIMICKING VASCULITIS (15 November, 2016)

  Bazo Raheem, Hina Khan, Neil Scolding, Seth Love, Safa Al-Sarraj, Ranj Bhangoo, Stephen Devereaux, Nicholas Rooney, Judith Sutak, Nicholas Moran
• 194: A SLIP OF THE TONGUE; A CASE OF DUAL DIAGNOSIS (15 November, 2016)

  Eimer Maloney, Ronan Killeen, Niall Swan, Sean O' Riordan
• 195: CEREBROSPINAL FLUID (CSF) CYTOLOGY: FACTORS IMPACTING ON DIAGNOSTIC YIELD (15 November, 2016)

  Antoinette O' Connor, Orla McFeely, Niamh Bermingham, Sean O' Sullivan
• 196: SAFETY AND UTILITY OF BRAINSTEM BIOPSY AND RESECTION (15 November, 2016)

  E Porretta, SM Jeffery, SL Jordan, J Male, RJ Edwards, S Love, NJ Scolding, CM Rice
• 197: TAKE THE BITTER WITH THE SWEET (15 November, 2016)

  Sharfaraz Salam, Parynaaz Fardoom, Tatiana Milahova
• 198: WHAT DOES NEUROLOGY ADD TO MANAGEMENT OF BRAIN TUMOUR RELATED EPILEPSY (BTRE)? (15 November, 2016)

  Shanika Samarasekera
• 199: SEMANTIC VERBAL FLUENCY IN PATIENTS WITH HEADACHE SUSPICIOUS OF BRAIN TUMOUR (15 November, 2016)

  Karolis Zienius, Simon Kerrigan, Sharon Harden, Robin Grant
• 200: CASE REPORT: PANDYSAUTONOMIA (15 November, 2016)

  Aseel Al-Ansari, Chrispother Rickards, Linzi Thomas, Steve Bain
• 201: EBV MENINGITIS AS A PRESENTING FEATURE OF GATA-2 DEFICIENCY (15 November, 2016)

  Omar AlMasri, Elizabeth Housheham, Brendan McLean
• 202: PREVALENCE AND PHENOTYPE OF EXTREME INTRACRANIAL HYPERTENSION (15 November, 2016)

  Andrew Barritt, Eva Bunting, Sarah Cooper
• 203: UNDERLYING GENETIC CAUSE IN CEREBELLAR ATAXIAS: EVALUATION OF AN IRISH COHORT (15 November, 2016)

  Petya Bogdanova-Mihaylova, Raymond PJ Murphy, Richard A Walsh, Sinéad M Murphy
• 204: NEOPLASTIC VENOUS OUTFLOW OBSTRUCTION; AN UNUSUAL CAUSE OF CEREBRAL VENOUS SINUS THROMBOSIS (15 November, 2016)

  Sarah Cook, Vahini Janarthen, Graham Warner
• 205: A THIRST FOR RARITY? AN INTERESTING CASE OF HYPOPITUITARISM (15 November, 2016)

  Marc Edwards, JA Johnston
• 206: NEAD/ FUNCTIONAL WEAKNESS – COMORBIDITIES & DIAGNOSIS EFFECT (15 November, 2016)

  Michael Truell, Stephan Hinze
• 207: HYPERAMMONAEMIA IN A PATIENT WITH ‘WALKING WOUNDED’ NON-CONVULSIVE STATUS (15 November, 2016)

  Akram A Hosseini, Elena Ailenei, Aaron Sturrock, Mary Anne Preece, Charlotte Dawson, Csaba Munkacsi
• 208: MILD IMMUNOSUPPRESSION CAUSING FATAL PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY (15 November, 2016)

  Akram Hosseini, Jason P Appelton, Martyn Carey, Satheesh Ramalingam, Edward Littleton
• 209: NO LAUGHING MATTER (15 November, 2016)

  Lliwen Jones, Rhys Thomas, Kathryn Peall, Thomas Massey, Stuart Moat, Robin Corkill, Trevor Pickersgill
• 210: A TREATABLE BUT ‘MISSABLE’ MYELOPATHY (15 November, 2016)

  Lliwen Jones, Ann Johnston
• 211: CENTRAL POSITIONAL NYSTAGMUS: A SYSTEMATIC LITERATURE REVIEW (15 November, 2016)

  Diego Kaski, Nora Macdonald, Yougan Saman, Amal Shaikhsulaiman, Amal Anwer, Doris Bamiou
• 212: LATE ONSET MANIA AS AN ORGANIC ILLNESS – A REVIEW OF CASE REPORTS (15 November, 2016)

  Hina Khan, Musa Sami, Ramin Nilforooshan
• 213: PERIPHERAL NEUROPATHY ASSOCIATED WITH WHIPPLE'S DISEASE (15 November, 2016)

  Guru Kumar, Mohamed Mohamed, Ian Redmond, Sreedharan Harikrishnan
• 214: EPILEPSIA PARTIALIS CONTINUA AND CJD; AN ATYPICAL PRESENTATION (15 November, 2016)

  Sara Leddy, Matthew Sheridan, Alvero Cervera
• 215: BRAIN NETWORK MODULATION WITH NON-INVASIVE BRAIN STIMULATION (15 November, 2016)

  Lucia Li, Ines Violante, Ewan Ross, Rob Leech, Adam Hampshire, David Carmichael, David Sharp
• 216: UTILISATION OF SIMULATION TRAINING IN NEUROLOGY (15 November, 2016)

  Heba Madi, Tahir Majeed
• 217: RECURRENT CEREBRAL VENOUS SINUS THROMBOSIS SECONDARY TO ELTROMBOPAG FOR ITP (15 November, 2016)

  Sana Mallick, Vahni Janarthen, Graham Warner
• 218: NEXT GENERATION NEUROLOGY (15 November, 2016)

  Deepti Marchment, Jon Rohrer, The ABNT Mentoring Team, Helen Devine
• 219: FACTORS INFLUENCING THE OUTCOME OF LUMBAR PUNCTURES. ARE WE LOSING OUR SKILL SET? (15 November, 2016)

  Ryan McCloskey, Ben Michael, Jay Panicker, Michael Bonello
• 220: ESTIMATING CAUSALITY OF THE NOVEL PRION PROTEIN GENE VARIANT T201S (15 November, 2016)

  Tze How Mok, Carolin Koriath, Tracy Campbell, Romi Saha, Thomas Clement Truelsen, Ambereen Parvez, John Collinge, Simon Mead
• 221: BRAIN BIOPSY IN CRYPTOGENIC NEUROLOGIC DISEASE (15 November, 2016)

  Datapwa Pamilerin Mujong, Ghaniah Hassan-Smith, John Woolmore
• 222: ASSESSING CEREBELLAR FUNCTION IN PRION DISEASE (15 November, 2016)

  Akin Nihat, Tze How Mok, John Collinge, Simon Mead
• 223: LA MALADIE DU PETIT PAPIER: QUANTITATIVE SURVEY, CLINICAL SIGNIFICANCE (15 November, 2016)

  A Randall, AJ Larner
• 224: PEG TUBE INSERTION IN NEURODEGENERATIVE DISEASE (15 November, 2016)

  Pamela Sarkar, Alice Cole, Neil Scolding, Claire Rice
• 225: SETTING UP AN UNDERGRADUATE NEUROLOGY TEACHING DAY: 7 STEPS (15 November, 2016)

  Kanchan Sharma
• 226: TRANSITION IN PAEDIATRIC NEUROLOGY: A 360 DEGREE PERSPECTIVE (15 November, 2016)

  Sukhvir Wright, Amparo Cavalle-Garcia, Benjamin Wright, Rajat Gupta, Shakti Agrawal, Bernie Concannon, Evangeline Wassmer
• 227: PINEAL CYST HAEMORRHAGE IN AN ANTICOAGULATED PATIENT (15 November, 2016)

  Jing Ming Yeo, Chandrasekaran Kaliaperumal
• 228: DANGERS ON THE ROAD FAILURES IN ‘DRIVING ADVICE IN NEUROLOGICAL DISORDERS’ (15 November, 2016)

  Bindu Yoga, Marc Randall
• 229: FOREIGN MATERIAL CEREBRAL EMBOLI FOLLOWING ENDOVASCULAR COILING (15 November, 2016)

  Jeremy Boardman, C Hilditch, G Roberts, H Raffalli-Ebezant, H Sonwalker, S Wuppalapati, S Mathur, Hedley Emsley
• 230: THE USE OF SMARTPHONE APPLICATIONS IN PATIENTS ATTENDING TIA CLINIC (15 November, 2016)

  Lisa Clayton, Agnes Dados, Robert Simister, Sumanjit Gill, Arvind Chandratheva
• 231: THE BENEFICIAL EFFECT OF COMBINING NEUROLOGY AND STROKE SERVICES (15 November, 2016)

  Gillian Ingram, Tom Hughes
• 232: GENERAL MEDICAL SKILLS ON NEUROLOGY AND STROKE WARDS (15 November, 2016)

  Gillian Ingram, Tom Hughes
• 233: ACUTE HEMIFIELD ROOM TILT ILLUSION IN CEREBRAL ISCHAEMIA (15 November, 2016)

  Justin Kinsella, Roisin Lonergan, Ronan Killeen, Chris McGuigan
• 234: ASSESSMENT OF PLATELET REACTIVITY WITH CEREBRAL MICROEMBOLI IN CAROTID STENOSIS (15 November, 2016)

  Justin Kinsella, Oliver Tobin, Sean Tierney, Timothy Feeley, Bridget Egan, Tara Coughlan, Ronan Collins, Desmond O'Neill, Joseph Harbison, Dominick McCabe
• 235: THE CLINICAL MANAGEMENT OF CEREBRAL VENOUS SINUS THROMBOSIS. A UK SURVEY (15 November, 2016)

  Tim Lavin, Martin Punter, Mark Holland
• 236: SPINAL CORD INFARCTION DUE TO NEUROFIBROMATOSIS TYPE 1 ASSOCIATED VASCULOPATHY (15 November, 2016)

  Tim Lavin, Christopher Murphy, John Ealing, Amit Herwadkar
• 237: USING ASL MRI TO CHARACTERISE DECLINE IN CEREBRAL BLOOD FLOW IN CADASIL (15 November, 2016)

  Fiona Moreton, Maria-Rosario Lopez Gonzalez, Keith Muir
• 238: NECK VESSEL DISSECTION FOLLOWING WHIPLASH-TYPE NECK INJURY (15 November, 2016)

  Richard Peatfield, Harri Jenkins
• 239: CASE PRESENTATION: THE DANCING MAN FROM SIERRA LEONE (15 November, 2016)

  Miriam Saey Al-Rifai, Afraim Salek-Haddadi